ACTRN12614001265662终止未知
The efficacy of palliative radiotherapy on symptomatic response as measured by PET scan and self-assessed pain response for patients with malignant pleural mesothelioma
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with histologically or cytologically confirmed malignant pleural mesothelioma (MPM
- •Patients with focal clinical symptoms likely to be caused by MPM as confirmed by prior imaging imaging (including non-pleural metastatic disease)
- •Clinical indication to undergo palliative radiotherapy in the opinion of the treating physician
- •Able to undergo study procedures
- •More than 6 weeks post radiotherapy (at the time of the PET scan)
- •More than 6 weeks post chemotherapy or surgery (at the time of the PET scan), or 3 weeks is acceptable if disease has progressed on most recent chemotherapy.
- •Able to undergo study procedures
- •Lesion/s to be treated is/are radiologically measurable as per modified RECIST or RECIST
- •Baseline pain score on VAS greater than or equal to 4 AND/OR MED is greater or equal to 10mg/24 hours
排除标准
- •Currently receiving chemotherapy or radiotherapy
- •Radiotherapy to same site
- •Intention to commence chemotherapy < 6 weeks post radiotherapy
- •Pregnant or breastfeeding at the time of study enrolment
- •Unable to provide signed informed consent
- •Inadequate English language to complete study outcome measures
- •Medical contraindication to palliative radiotherapy
- •Geographically inaccessible for follow-up
- •Less than 18 years of age
研究者
相似试验
已完成
不适用
Prospective study of efficacy of palliative radiotherapy for advanced inoperable gastric cancer with active bleedinggastric cancerJPRN-UMIN000026362Asahi University31
已完成
不适用
Investigation on radiotherapy treatment effect using perfusion and diffusion-weighted MR imagingtumorJPRN-UMIN000014439Kyoto Univerisity Hospital
已完成
2 期
Phase II study of palliative radiotherapy combined with Zoledronic Acid Hydrate for metastatic bone tumor from renal cell carcinomaRenal cancerJPRN-UMIN000007836Shizuoka Cancer Center Japanese Radiation Oncology Study Group30
已完成
不适用
Quality of Life After Conformal Radiotherapy in Late Stage Oral Cavity Cancer:A Prospective clinical TrialCTRI/2018/03/012441Jawaharlal Institue of Postgraduate Medical Education and research25
进行中（未招募）
1 期
ABiochemically-relapsing prostate adenocarcinoma following radical prostatectomy.MedDRA version: 14.1 Level: LLT Classification code 10001186 Term: Adenocarcinoma of prostate System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-004831-30-FRICANCER43